A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF - Trial NCT06335082
Access comprehensive clinical trial information for NCT06335082 through Pure Global AI's free database. This phase not specified trial is sponsored by Heart Rhythm Clinical and Research Solutions, LLC and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 900 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Heart Rhythm Clinical and Research Solutions, LLC
Timeline & Enrollment
N/A
Apr 15, 2024
Jan 30, 2027
Primary Outcome
Long term effectiveness,Long-term safety
Summary
The DISRUPT-AF Registry is an observational, prospective, multi-center, non-randomized,
 real-world registry designed to obtain clinical experience with the Farapulse Pulsed Field
 Ablation System for the treatment of atrial fibrillation (AF).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06335082
Device Trial